Presentation is loading. Please wait.

Presentation is loading. Please wait.

Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial  Lauren Okon, MD, Misha Rosenbach, MD, Michael.

Published byHengki Deddy Gunardi Modified over 5 years ago

Similar presentations

Presentation on theme: "Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial  Lauren Okon, MD, Misha Rosenbach, MD, Michael."— Presentation transcript:

1 Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial  Lauren Okon, MD, Misha Rosenbach, MD, Michael Krathen, MD, Mathew Rose, MS, Kathleen Propert, ScD, Joyce Okawa, RN, Victoria Werth, MD  Journal of the American Academy of Dermatology  Volume 70, Issue 3, Pages (March 2014) DOI: /j.jaad Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 Discoid lupus. Patient 1's discoid lupus lesions at week 0 (A) and week 24 (B). Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions

Download ppt "Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial  Lauren Okon, MD, Misha Rosenbach, MD, Michael."

Similar presentations

Primary cutaneous anaplastic large cell lymphoma in a patient receiving adalimumab Chad J. Hruska, MD, Robert J. Bertoli, MD, Yorke D. Young, MD, Patrick.

Primary cutaneous anaplastic large cell lymphoma in a patient receiving adalimumab Chad J. Hruska, MD, Robert J. Bertoli, MD, Yorke D. Young, MD, Patrick.
Treatment of generalized lichen nitidus with narrowband ultraviolet B Jae-Hong Park, MD, Yun-Lim Choi, MD, Won-Serk Kim, MD, Dong-Youn Lee, MD, Jun-Mo.

Treatment of generalized lichen nitidus with narrowband ultraviolet B Jae-Hong Park, MD, Yun-Lim Choi, MD, Won-Serk Kim, MD, Dong-Youn Lee, MD, Jun-Mo.
Optimal time to provide skin cancer and photoprotection education to pediatric solid organ transplant recipients  Lily Chen, BA, Feng Gao, MD, PhD, MPH,

Optimal time to provide skin cancer and photoprotection education to pediatric solid organ transplant recipients  Lily Chen, BA, Feng Gao, MD, PhD, MPH,
Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH 

Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH 
Kavitha K. Reddy, MD, Jeremy A. Brauer, MD, Roy G. Geronemus, MD 

Kavitha K. Reddy, MD, Jeremy A. Brauer, MD, Roy G. Geronemus, MD 
Lesions referred to dermatology in the Department of Veterans Affairs (VA) health system: A retrospective chart review  Katherine R. Grey, BA, Jaime L.

Lesions referred to dermatology in the Department of Veterans Affairs (VA) health system: A retrospective chart review  Katherine R. Grey, BA, Jaime L.
Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous leishmania major infection: A randomized.

Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous leishmania major infection: A randomized.
A girl with a solitary red bulla

A girl with a solitary red bulla
Striking leflunomide efficacy against refractory cutaneous sarcoidosis

Striking leflunomide efficacy against refractory cutaneous sarcoidosis
Yul W. Yang, MD, PhD, David J. DiCaudo, MD 

Yul W. Yang, MD, PhD, David J. DiCaudo, MD 
Blaschkoid pityriasis rosea

Blaschkoid pityriasis rosea
Image registration of sequential transparent photographs to localize and detect new versus recurrent tumors in dermatologic and Mohs micrographic surgery 

Image registration of sequential transparent photographs to localize and detect new versus recurrent tumors in dermatologic and Mohs micrographic surgery 
Baldness reversed by chemotherapy

Baldness reversed by chemotherapy
Megan Wood, MD, Tom Raisanen, MD, Ingrid Polcari, MD 

Megan Wood, MD, Tom Raisanen, MD, Ingrid Polcari, MD 
Array of cutaneous adverse effects associated with sorafenib

Array of cutaneous adverse effects associated with sorafenib
Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD 

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD 
María Jesús Suárez Valladares, MD, Manuel Ángel Rodríguez Prieto, MD 

María Jesús Suárez Valladares, MD, Manuel Ángel Rodríguez Prieto, MD 
Vaishali Patel, PharmD, Elizabeth J. Horn, PhD, Steve J

Vaishali Patel, PharmD, Elizabeth J. Horn, PhD, Steve J
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to.

Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to.
The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study  Hsien-Yi Chiu, MD, Tsen-Fang.

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study  Hsien-Yi Chiu, MD, Tsen-Fang.

Similar presentations

Ads by Google